042-032 |
208* |
42 |
1 |
300 |
5 |
Urinary
Incontinence Elective Surgery |
050-005 |
208* |
40 |
F |
300 |
46 |
Schwannoma
Elective Surgery |
063-002 |
208* |
47 |
M |
300 |
36 |
Basal
Cell Carncinoma [Carcinoma] |
069-010 |
208* |
49 |
F |
300 |
Prolonged |
Cerebral
Aneurysm |
074-013 |
208* |
32 |
M |
300 |
1 |
Homicide
Victim |
077-019 |
208* |
63 |
F |
300 |
Prolonged |
Cerebrovascular
Accident |
078-006 |
208* |
66 |
M |
300 |
1 |
Myocardial
Infarction |
081-011 |
208* |
34 |
F |
300 |
1 |
Overdose/Seizure |
090-022 |
208* |
35 |
M |
300 |
1 |
Overdose/Generalized
Convulsive Seizure |
090-040 |
208* |
32 |
M |
300 |
1 |
Overdose |
092-012 |
208* |
54 |
M |
200 |
4 |
Myocardial
Infarction |
097-005 |
208* |
60 |
M |
100 |
Prolonged |
Prostate
Carcinoma |
102-001 |
208* |
31 |
M |
200 |
2 |
Lumbosental
Disc Elective Herniorraphy |
* Patient
was in continuation phase of protocol beyond eight-week trial period
Bupropion
Sustained-Release Clinical Review 66
Back a Page
Next Section - Addendum to Review and Evaluation of Clinical Data: Summary of Protocol 212 For Wellbutrin SR NDA
Back to Wellbutrin SRŪ NDA Index Page
Back to Main
Index